GSRRX | VVIAX | GSRRX / VVIAX | |
Total Expense Ratio | 1.26 | 0.05 | 2,520% |
Annual Report Gross Expense Ratio | 1.52 | 0.05 | 3,040% |
Fund Existence | 13 years | 25 years | - |
Gain YTD | 5.225 | 6.714 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 442M | 195B | 0% |
Annual Yield % from dividends | 1.22 | 2.18 | 56% |
Returns for 1 year | -4.44 | 9.75 | -46% |
Returns for 3 years | 6.24 | 34.32 | 18% |
Returns for 5 years | 30.15 | 74.87 | 40% |
Returns for 10 years | -36.06 | 116.26 | -31% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IHI | 61.43 | 0.75 | +1.24% |
iShares US Medical Devices ETF | |||
GSC | 50.97 | 0.41 | +0.81% |
Goldman Sachs Small Cap Equity ETF | |||
QLTI | 25.79 | 0.04 | +0.14% |
GMO International Quality ETF | |||
DBND | 45.85 | 0.06 | +0.13% |
DoubleLine Opportunistic Core Bond ETF | |||
KEMQ | 22.94 | -0.37 | -1.58% |
KraneShares Em Mkts Cnsmr Tech ETF |